Reduced incidence of ovarian hyperstimulation syndrome by prophylactic infusion of hydroxyaethyl starch solution in an in-vitro fertilization programme

被引:32
作者
Graf, MA [1 ]
Fischer, R [1 ]
Naether, OGJ [1 ]
Baukloh, V [1 ]
Tafel, J [1 ]
Nückel, M [1 ]
机构
[1] Endokrinol Praxisgemeinschaft Hamburg, IVF Unit, D-22767 Hamburg, Germany
关键词
in-vitro fertilization; human serum albumin infusion; hydroxyaethyl starch infusion; ovarian hyperstimulation syndrome; prophylactic therapy;
D O I
10.1093/humrep/12.12.2599
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Prophylactic infusion of human serum albumin can reduce or mitigate severe ovarian hyperstimulation syndrome (OHSS) in patients at high risk, Recently, concern has been expressed in the lay press regarding the potential viral transmissions with blood constituents. Hence, we looked for a safe non-biological substitute,vith comparable physical properties in order to cope with this concern, One hundred patients of our in-vitro fertilization (IVF) programme with oestradiol serum concentrations greater than or equal to 11010 pmol/l on the day of human chorionic gonadotrophin injection and/or greater than or equal to 20 oocytes retrieved and/or previous severe OHSS mere infused with 1000 ml 6% hydroxyaethyl starch solution at the time of oocyte collection and 500 ml 48 h later, A total of 82 IVF patients at risk without prophylactic infusions during the preceding years served as controls, Both groups were identical according to patient's age, body mass index, androgen concentrations, peak oestradiol concentrations, number of retrieved oocytes, fertilization and pregnancy rates, There were seven cases of severe OHSS in untreated patients and two cases in the treatment group (P = 0.08). In moderate OHSS a significant difference became obvious with only ten cases in the treatment group and 32 cases in the control group (P < 0.00001). Hydroxyaethyl starch solution seems to be an effective and economic alternative in reducing severe and moderate OHSS during IVF treatment.
引用
收藏
页码:2599 / 2602
页数:4
相关论文
共 25 条
[1]   Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome [J].
Abramov, Y ;
Barak, V ;
Nisman, B ;
Schenker, JG .
FERTILITY AND STERILITY, 1997, 67 (02) :261-265
[2]   THE USE OF INTRAVENOUS ALBUMIN IN PATIENTS AT HIGH-RISK FOR SEVERE OVARIAN HYPERSTIMULATION SYNDROME [J].
ASCH, RH ;
IVERY, G ;
GOLDSMAN, M ;
FREDERICK, JL ;
STONE, SC ;
BALMACEDA, JP .
HUMAN REPRODUCTION, 1993, 8 (07) :1015-1020
[3]  
ASCH RH, 1994, HUM REPROD, V9, P753, DOI 10.1093/oxfordjournals.humrep.a138586
[4]   SEVERE OVARIAN HYPERSTIMULATION SYNDROME IN ASSISTED REPRODUCTIVE TECHNOLOGY - DEFINITION OF HIGH-RISK GROUPS [J].
ASCH, RH ;
LI, HP ;
BALMACEDA, JP ;
WECKSTEIN, LN ;
STONE, SC .
HUMAN REPRODUCTION, 1991, 6 (10) :1395-1399
[5]   Prorenin and active renin concentrations in plasma and ascites during severe ovarian hyperstimulation syndrome [J].
Delbaere, A ;
Bergmann, PJM ;
GervyDecoster, C ;
Camus, M ;
deMaertelaer, V ;
Englert, Y .
HUMAN REPRODUCTION, 1997, 12 (02) :236-240
[6]   Internal jugular vein thrombosis: A late complication of ovarian hyperstimulation syndrome despite mini-dose heparin prophylaxis [J].
Hignett, M ;
Spence, JEH ;
Claman, P .
HUMAN REPRODUCTION, 1995, 10 (12) :3121-3123
[7]   Does intravenous administration of human albumin prevent severe ovarian hyperstimulation syndrome? [J].
Lewit, N ;
Kol, S ;
Ronen, N ;
ItskovitzEldor, J .
FERTILITY AND STERILITY, 1996, 66 (04) :654-656
[8]  
Lewit N, 1996, HUM REPROD, V11, P1399
[9]   SUBCLAVIAN VEIN-THROMBOSIS - A LATE COMPLICATION OF OVARIAN HYPERSTIMULATION SYNDROME [J].
MILLS, MS ;
EDDOWES, HA ;
FOX, R ;
WARDLE, PG .
HUMAN REPRODUCTION, 1992, 7 (03) :370-371
[10]   DOES INTRAVENOUS ALBUMIN PREVENT OVARIAN HYPERSTIMULATION SYNDROME [J].
MORRIS, RS ;
PAULSON, RJ .
HUMAN REPRODUCTION, 1994, 9 (04) :753-753